| Health / Medical Topics |
Tyrosine Kinase Inhibitor OSI-930
A selective thiophene-derived tyrosine kinase inhibitor with potential antineoplastic activity. Tyrosine kinase inhibitor OSI-930 inhibits stem cell factor receptor (c-Kit) and the vascular endothelial growth factor receptor 2 (VEGFR2), which may result in the inhibition of both tumor cell proliferation and tumor angiogenesis. Both c-Kit and VEGFR2 are overexpressed in a variety of cancers. (NCI Thesaurus)
YOU MAY ALSO LIKE
A substance being studied in the treatment of some types of cancer. Tyrosine kinase inhibitor BIBF 1120 blocks enzymes needed for cells…
A substance that blocks the action of enzymes called tyrosine kinases. Tyrosine kinases are a part of many cell functions, including cell…
A protein domain that binds a protein and catalyzes the covalent addition of a phosphate group specifically to a tyrosine residue. …
Any substance that inhibits tyrosine 3-monooxygenase (tyrosine hydroxylase), an enzyme that catalyzes the conversion of tyrosine to dihydroxyphenylalanine, a precursor to dopamine,…
The determination of the amount of tyrosine crystals present in a sample.
Encoded by human YWHAQ Gene, 245-amino acid 27.8 kD YWHAQ Protein is a cytoplasmic homodimeric 14-3-3 family protein. 14-3-3 proteins are localized…
